Metal ions and degenerative diseases

Liliana Quintanar,Mi Hee Lim

DOI: https://doi.org/10.1007/s00775-019-01744-4

2019-11-23

JBIC Journal of Biological Inorganic Chemistry

Abstract:As life expectancy of human beings has increased, so has the incidence of degenerative diseases with aging as an important risk factor. Alzheimer´s disease (AD) affects approximately 47 million people worldwide, while Parkinson´s disease (PD) is the second most common neurodegenerative disorder. While these neurodegenerative diseases have a multifactorial etiology, in both cases, protein misfolding and accumulation of amyloid aggregates in the brain are observed. Another amyloid deposition pathology is type 2 diabetes, a chronic degenerative disease affecting almost 400 million people worldwide. Metal ions have been implicated in these and other degenerative diseases, as several of the proteins undergoing amyloid aggregation have been identified as metal-binding proteins. Key examples include α-synuclein, a Cu-binding protein that constitutes the main component in Lewy bodies in PD, and the amyloid-β peptide (Aβ) that accumulates, along with Cu, Fe and Zn, in AD plaques. While the physiological function of these metal-binding proteins is not well understood, the role of the metal–protein interactions in the etiology of each disease is even less clear. The metals implicated include essential metal ions, such as Cu, Zn, Fe and Mn, for which their homeostasis may be perturbed at a late age. Additionally, exposure to xenobiotic metals, such as Pb, Hg, and Cd, and metalloids, such as As, has also been associated with toxicity and neurodegeneration [<span class="CitationRef"><a href="#CR1">1</a></span>].